202 related articles for article (PubMed ID: 14567030)
1. Pharmacokinetics of intraperitoneal mitomycin C.
van Ruth S; Verwaal VJ; Zoetmulder FA
Surg Oncol Clin N Am; 2003 Jul; 12(3):771-80. PubMed ID: 14567030
[TBL] [Abstract][Full Text] [Related]
2. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies.
Jacquet P; Averbach A; Stephens AD; Stuart OA; Chang D; Sugarbaker PH
Oncology; 1998; 55(2):130-8. PubMed ID: 9499187
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal chemohyperthermic perfusion.
Cerretani D; Nencini C; Urso R; Giorgi G; Marrelli D; De Stefano A; Pinto E; Cioppa T; Nastri G; Roviello F
J Chemother; 2005 Dec; 17(6):668-73. PubMed ID: 16433199
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.
Rossi CR; Mocellin S; Pilati P; Foletto M; Quintieri L; Palatini P; Lise M
Surg Oncol Clin N Am; 2003 Jul; 12(3):781-94. PubMed ID: 14567031
[TBL] [Abstract][Full Text] [Related]
5. Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis.
Sørensen O; Andersen AM; Kristian A; Giercksky KE; Flatmark K
J Surg Oncol; 2014 May; 109(6):521-6. PubMed ID: 24347444
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C.
Sugarbaker PH; Stuart OA; Carmignani CP
Cancer Chemother Pharmacol; 2006 May; 57(5):703-8. PubMed ID: 16096789
[TBL] [Abstract][Full Text] [Related]
7. Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.
Kemmel V; Mercoli HA; Meyer N; Brumaru D; Romain B; Lessinger JM; Brigand C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S873-9. PubMed ID: 26100819
[TBL] [Abstract][Full Text] [Related]
8. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics.
de Lima Vazquez V; Stuart OA; Mohamed F; Sugarbaker PH
Cancer Chemother Pharmacol; 2003 Aug; 52(2):108-12. PubMed ID: 12759776
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres.
Rump AF; Woschée U; Theisohn M; Fischbach R; Heindel W; Lackner K; Klaus W
Eur J Clin Pharmacol; 2002 Oct; 58(7):459-65. PubMed ID: 12389068
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
Morgan RJ; Doroshow JH; Synold T; Lim D; Shibata S; Margolin K; Schwarz R; Leong L; Somlo G; Twardowski P; Yen Y; Chow W; Lin P; Paz B; Chu D; Frankel P; Stalter S
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5896-901. PubMed ID: 14676112
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of mitomycin C following a high-dose continuous hyperthermic peritoneal perfusion].
Hamazoe R; Koga S; Maeta M; Shimizu N; Sumi K; Oda M; Karino T; Yamane T; Kanayama H; Osaki Y
Gan To Kagaku Ryoho; 1984 Jan; 11(1):97-103. PubMed ID: 6421245
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases.
Schneebaum S; Arnold MW; Staubus A; Young DC; Dumond D; Martin EW
Ann Surg Oncol; 1996 Jan; 3(1):44-50. PubMed ID: 8770301
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy.
van Ruth S; Mathôt RA; Sparidans RW; Beijnen JH; Verwaal VJ; Zoetmulder FA
Clin Pharmacokinet; 2004; 43(2):131-43. PubMed ID: 14748621
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the antineoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma.
Meyer F; Ridwelski K; Gebauer T; Grote R; Martens-Lobenhoffer J; Lippert H
Chemotherapy; 2005 Mar; 51(1):1-8. PubMed ID: 15722626
[TBL] [Abstract][Full Text] [Related]
15. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
[TBL] [Abstract][Full Text] [Related]
16. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.
Elias D; Bonnay M; Puizillou JM; Antoun S; Demirdjian S; El OA; Pignon JP; Drouard-Troalen L; Ouellet JF; Ducreux M
Ann Oncol; 2002 Feb; 13(2):267-72. PubMed ID: 11886004
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C.
Lange KN; McKay D; Gentry BG; Franko J
Ann Surg Oncol; 2017 Dec; 24(13):3837-3841. PubMed ID: 29019106
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
[TBL] [Abstract][Full Text] [Related]
19. High-dose mitomycin C in isolated hyperthermic liver perfusion for unresectable liver metastases.
Oldhafer KJ; Frerker MK; Lang H; Fauler J; Flemming P; Schmoll E; Nadalin S; Moreno L; Pichlmayr R
J Invest Surg; 1998; 11(6):393-400. PubMed ID: 9895113
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia.
Chalret du Rieu Q; White-Koning M; Picaud L; Lochon I; Marsili S; Gladieff L; Chatelut E; Ferron G
Cancer Chemother Pharmacol; 2014 Sep; 74(3):571-82. PubMed ID: 25053386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]